Laura Biganzoli - Researcher Profile

Publications

3 shown

EORTC 10968: a phase I clinical and pharmacokinetic study of polyethylene glycol liposomal doxorubicin (Caelyx®, Doxil®) at a 6-week interval in patients with metastatic breast cancer

Anne Hamilton , Laura Biganzoli , Robert E. Coleman +9 more

2002 Annals of Oncology 104 citations

5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)

Binghe Xu , Larry Norton , A. Costa +42 more

2020 Annals of Oncology 1244 citations

4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)

Fátima Cardoso , Elżbieta Senkus , A. Costa +39 more

Advanced Breast Cancer (ABC) comprises both locally advanced breast cancer (LABC) and metastatic breast cancer (MBC) [1]. Although treatable, MBC remains virtually an incurable ...

2018 Annals of Oncology 1127 citations

Frequent Co-Authors

Researcher Info

h-index: 3
Publications: 3
Citations: 2,475
Institution: Ospedale di Prato Santo Stefano

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0001-7989-8658

Impact Metrics

h-index 3

h-index: Number of publications with at least h citations each.